Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01595802 · ClinicalTrials.gov registry record
Non-Significant Risk Study Comparing the Nautilus NeuroWaveTM to Transcranial Doppler as an Aid to Diagnosing Vasospasm
A clinical trial, sponsored by Jan Medical.
- Completed
- Registry status
- 92
- Enrollment target
NCT01595802 is a clinical trial that has completed, run by Jan Medical. The registered enrollment target is 92 participants.
The verdict
NCT01595802 has completed, sponsored by Jan Medical.
- COMPLETED
- Registry status
- 92 participants
- Enrollment target
Study Summary
The purpose of the study is to determine the sensitivity, specificity and predictive values of the Jan Medical NeuroWave System in detecting moderate and severe vasospasm in comparison to Trans Cranial Doppler(TCD).
Interventions
- DEVICE Transcranial Doppler (TCD)
- DEVICE Nautilus NeuroWave
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 92 participants |
| Start Date | 2012-01 |
| Est. Completion | 2015-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01595802
The ClinicalTrials.gov registry entry for NCT01595802 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 92 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Jan Medical, which has 9 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Transcranial Doppler (TCD) is the first listed.
NCT01595802 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01595802 about?
NCT01595802 is a clinical study titled "Non-Significant Risk Study Comparing the Nautilus NeuroWaveTM to Transcranial Doppler as an Aid to Diagnosing Vasospasm". The purpose of the study is to determine the sensitivity, specificity and predictive values of the Jan Medical NeuroWave System in detecting moderate and severe vasospasm in comparison to Trans Cranial Doppler(TCD).
What is the current status of trial NCT01595802?
This trial is currently completed. The enrollment target is 92 participants. The study started on 2012-01. Estimated completion is 2015-07.
What interventions are being tested in trial NCT01595802?
The interventions under investigation include: Transcranial Doppler (TCD) (DEVICE), Nautilus NeuroWave (DEVICE).
Who is sponsoring clinical trial NCT01595802?
This trial is sponsored by Jan Medical, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.